Novel Drug and Gene Delivery System and Imaging Agent Based on Marine Diatom Biosilica Nanoparticles

Overview

Journal Mar Drugs

Publisher MDPI

Specialties Biology
Pharmacology

Date 2022 Aug 25

PMID 36005484

Authors

Hanaa Ali Hussein

Muhammad Shahid Nazir

Nizakat Azra

Zeenat Qamar

Azman Seeni

Tengku Ahmad Damitri Al-Astani Tengku Din

Mohd Azmuddin Abdullah

Affiliations

Soon will be listed here.

Abstract

Mesoporous silica nanoparticles (MSNs) have great potential for applications as a drug delivery system (DDS) due to their unique properties such as large pore size, high surface area, biocompatibility, biodegradability, and stable aqueous dispersion. The MSN-mediated DDS can carry chemotherapeutic agents, optical sensors, photothermal agents, short interfering RNA (siRNA), and gene therapeutic agents. The MSN-assisted imaging techniques are applicable in cancer diagnosis. However, their synthesis via a chemical route requires toxic chemicals and is challenging, time-consuming, and energy-intensive, making the process expensive and non-viable. Fortunately, nature has provided a viable alternative material in the form of biosilica from marine resources. In this review, the applications of biosilica nanoparticles synthesized from marine diatoms in the field of drug delivery, biosensing, imaging agents, and regenerative medicine, are highlighted. Insights into the use of biosilica in the field of DDSs are elaborated, with a focus on different strategies to improve the physico-chemical properties with regards to drug loading and release efficiency, targeted delivery, and site-specific binding capacity by surface functionalization. The limitations, as well as the future scope to develop them as potential drug delivery vehicles and imaging agents, in the overall therapeutic management, are discussed.

Citing Articles

Application of Nanoparticles for Immunotherapy of Allergic Rhinitis.

Li K, Jin J, Yang Y, Luo X, Wang Y, Xu A Int J Nanomedicine. 2024; 19:12015-12037.

PMID: 39583318 PMC: 11584337. DOI: 10.2147/IJN.S484327.

Antimicrobial and Hemostatic Diatom Biosilica Composite Sponge.

Youn S, Ki M, Min K, Abdelhamid M, Pack S Antibiotics (Basel). 2024; 13(8).

PMID: 39200014 PMC: 11350910. DOI: 10.3390/antibiotics13080714.

Organic and Biogenic Nanocarriers as Bio-Friendly Systems for Bioactive Compounds' Delivery: State-of-the Art and Challenges.

Petrovic S, Barbinta-Patrascu M Materials (Basel). 2023; 16(24).

PMID: 38138692 PMC: 10744464. DOI: 10.3390/ma16247550.

Recent Progress in Diatom Biosilica: A Natural Nanoporous Silica Material as Sustained Release Carrier.

Lim H, Seo Y, Kwon D, Kang S, Yu J, Park H Pharmaceutics. 2023; 15(10).

PMID: 37896194 PMC: 10609864. DOI: 10.3390/pharmaceutics15102434.

Photochemical Reduction of Silver Nanoparticles on Diatoms.

Leon-Valencia A, Briceno S, Reinoso C, Vizuete K, Debut A, Caetano M Mar Drugs. 2023; 21(3).

PMID: 36976234 PMC: 10054479. DOI: 10.3390/md21030185.

References

He X, Zhao Y, He D, Wang K, Xu F, Tang J . ATP-responsive controlled release system using aptamer-functionalized mesoporous silica nanoparticles. Langmuir. 2012; 28(35):12909-15. DOI: 10.1021/la302767b. View

Zhu W, Wan L, Zhang C, Gao Y, Zheng X, Jiang T . Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate. Mater Sci Eng C Mater Biol Appl. 2013; 34:78-85. DOI: 10.1016/j.msec.2013.08.014. View

Tian G, Sun X, Bai J, Dong J, Zhang B, Gao Z . Doxorubicin‑loaded dual‑functional hyaluronic acid nanoparticles: Preparation, characterization and antitumor efficacy in vitro and in vivo. Mol Med Rep. 2018; 19(1):133-142. PMC: 6297777. DOI: 10.3892/mmr.2018.9687. View

Xia T, Kovochich M, Liong M, Meng H, Kabehie S, George S . Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano. 2009; 3(10):3273-86. PMC: 3900639. DOI: 10.1021/nn900918w. View

Martinez-Carmona M, Lozano D, Baeza A, Colilla M, Vallet-Regi M . A novel visible light responsive nanosystem for cancer treatment. Nanoscale. 2017; 9(41):15967-15973. DOI: 10.1039/c7nr05050j. View

Karakoy M, Gultepe E, Pandey S, Khashab M, Gracias D . Silane surface modification for improved bioadhesion of esophageal stents. Appl Surf Sci. 2015; 311:684-689. PMC: 4313738. DOI: 10.1016/j.apsusc.2014.05.136. View

Hu L, Sun H, Zhao Q, Han N, Bai L, Wang Y . Multilayer encapsulated mesoporous silica nanospheres as an oral sustained drug delivery system for the poorly water-soluble drug felodipine. Mater Sci Eng C Mater Biol Appl. 2014; 47:313-24. DOI: 10.1016/j.msec.2014.10.067. View

Yang X, Chen L, Li Y, Rooke J, Sanchez C, Su B . Hierarchically porous materials: synthesis strategies and structure design. Chem Soc Rev. 2016; 46(2):481-558. DOI: 10.1039/c6cs00829a. View

Carvalho A, Cordeiro R, Faneca H . Silica-Based Gene Delivery Systems: From Design to Therapeutic Applications. Pharmaceutics. 2020; 12(7). PMC: 7407166. DOI: 10.3390/pharmaceutics12070649. View

10.

DeFrates K, Markiewicz T, Gallo P, Rack A, Weyhmiller A, Jarmusik B . Protein Polymer-Based Nanoparticles: Fabrication and Medical Applications. Int J Mol Sci. 2018; 19(6). PMC: 6032199. DOI: 10.3390/ijms19061717. View

11.

Hu Y, Zhi Z, Wang T, Jiang T, Wang S . Incorporation of indomethacin nanoparticles into 3-D ordered macroporous silica for enhanced dissolution and reduced gastric irritancy. Eur J Pharm Biopharm. 2011; 79(3):544-51. DOI: 10.1016/j.ejpb.2011.07.001. View

12.

Cheng Y, Qin S, Ma Y, Chen X, Zhang A, Zhang X . Super-pH-Sensitive Mesoporous Silica Nanoparticle-Based Drug Delivery System for Effective Combination Cancer Therapy. ACS Biomater Sci Eng. 2021; 5(4):1878-1886. DOI: 10.1021/acsbiomaterials.9b00099. View

13.

Terracciano M, De Stefano L, Rea I . Diatoms Green Nanotechnology for Biosilica-Based Drug Delivery Systems. Pharmaceutics. 2018; 10(4). PMC: 6321530. DOI: 10.3390/pharmaceutics10040242. View

14.

Bhat R, Ribes A, Mas N, Aznar E, Sancenon F, Marcos M . Thrombin-Responsive Gated Silica Mesoporous Nanoparticles As Coagulation Regulators. Langmuir. 2016; 32(5):1195-200. DOI: 10.1021/acs.langmuir.5b04038. View

15.

Sirsi S, Borden M . State-of-the-art materials for ultrasound-triggered drug delivery. Adv Drug Deliv Rev. 2014; 72:3-14. PMC: 4041842. DOI: 10.1016/j.addr.2013.12.010. View

16.

Jafari S, Derakhshankhah H, Alaei L, Fattahi A, Shiri Varnamkhasti B, Saboury A . Mesoporous silica nanoparticles for therapeutic/diagnostic applications. Biomed Pharmacother. 2018; 109:1100-1111. DOI: 10.1016/j.biopha.2018.10.167. View

17.

Saxena A, Tiwari A, Kaushik R, Iqbal H, Parra-Saldivar R . Diatoms recovery from wastewater: Overview from an ecological and economic perspective. J Water Process Eng. 2024; 39:101705. PMC: 7562967. DOI: 10.1016/j.jwpe.2020.101705. View

18.

He X, Wang K, Tan W, Liu B, Lin X, He C . Bioconjugated nanoparticles for DNA protection from cleavage. J Am Chem Soc. 2003; 125(24):7168-9. DOI: 10.1021/ja034450d. View

19.

Chao J, Biggs M, Pandit A . Diatoms: a biotemplating approach to fabricating drug delivery reservoirs. Expert Opin Drug Deliv. 2014; 11(11):1687-95. DOI: 10.1517/17425247.2014.935336. View

20.

Hong E, Choi D, Shim M . Targeted and effective photodynamic therapy for cancer using functionalized nanomaterials. Acta Pharm Sin B. 2016; 6(4):297-307. PMC: 4951583. DOI: 10.1016/j.apsb.2016.01.007. View